Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Zenagamtide

A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Semagl

Novo Nordisk · Phase 1 · Recruiting · Enrollment 60

NCT07855133

No selected arm has a reported week for this endpoint.

    A solid line connects the weeks the source reports.